CTCA Southwestern ( Site 0060)

Tulsa, Oklahoma 74133

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Breast Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Status: Enrolling, Phase III
Updated: 12/31/1969
CTCA Southwestern ( Site 0060)
mi
from
Tulsa, OK
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
Status: Enrolling, Phase III
Updated: 12/31/1969
CTCA Southwestern ( Site 0060)
mi
from
Tulsa, OK
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799).
Status: Enrolling, Phase II
Updated: 12/31/1969
CTCA Southwestern ( Site 0060)
mi
from
Tulsa, OK
Click here to add this to my saved trials